Spotlight -

Geographic Atrophy

Patricio Schlottmann, MD

Articles by Patricio Schlottmann, MD

Patricio Schlottmann, MD, highlights 4-year extension data during EURETINA 2025

ByPatricio Schlottmann, MD,Hattie Hayes,Martin David Harp,Sydney M Crago

October 8th 2025

Latest Updated Articles

Trending on Modern Retina

AAVantgarde’s AAVB-039 gene therapy to treat Stargardt disease receives orphan drug status from FDA

AAO 2025: Imagine what can happen during this collective experience

Patricio Schlottmann, MD, highlights 4-year extension data during EURETINA 2025

FDA clears IND for Complement Therapeutics’ CTx001 gene therapy in geographic atrophy

© 2025 MJH Life Sciences^®

All rights reserved.